Memphis Grizzlies fans can breathe a sigh of relief as forward/center Brandon Clarke is set to return for the start of next season after opting for an injection treatment for his injured right knee, rather than undergoing surgery. The decision comes after Clarke suffered a high-grade PCL sprain during a game against Portland in March, ruling him out for the remainder of the current season. This injury marks the second substantial lower-body setback for Clarke, who previously dealt with a torn left Achilles tendon. Despite these challenges, the 28-year-old appeared in 64 games this season, showcasing his value on the court by averaging 8.3 points and 5.1 rebounds in under 19 minutes per game.
The Grizzlies emphasized that the choice to pursue non-surgical treatment for Clarke's knee was reached after extensive consultations and is supported by the medical team. With Clarke already receiving the necessary injection, all eyes are now on his recovery process as he aims to bounce back stronger in the upcoming season. His presence will be crucial for Memphis, especially with two years and $25 million remaining on his current contract. Fans can expect Clarke to continue making an impact on the court, displaying his athleticism and versatility in the Grizzlies' lineup.